Intra- and intertumor heterogeneity in patients with multiple lung adenocarcinomas.
Molecular profile may distinguish synchronous from methacronous lung carcinomas.
Molecular patterns may also identify subclonal genetic alterations in lung cancer.
Molecular findings may affect the treatment choice and the clinical outcome.